TWO SIGMA ADVISERS, LP - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 250 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.9%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q2 2022$12,181,000
+20.6%
83,600
-1.9%
0.04%
+29.6%
Q1 2022$10,102,000
+53.4%
85,200
+78.2%
0.03%
+68.8%
Q4 2021$6,587,000
+21.9%
47,800
+22.9%
0.02%
+14.3%
Q3 2021$5,404,000
+223.6%
38,900
+59.2%
0.01%
+180.0%
Q1 2021$1,670,000
-74.7%
24,430
-68.3%
0.01%
-72.2%
Q4 2020$6,611,000
-27.5%
77,130
-45.0%
0.02%
-30.8%
Q3 2020$9,116,000
+6.9%
140,230
+20.2%
0.03%
+4.0%
Q2 2020$8,527,000
+49.0%
116,630
-30.6%
0.02%
+13.6%
Q1 2020$5,721,000
-65.5%
168,130
-44.7%
0.02%
-42.1%
Q4 2019$16,562,000
+52.1%
304,230
+16.5%
0.04%
+40.7%
Q3 2019$10,890,000
+30.2%
261,030
+36.7%
0.03%
+28.6%
Q2 2019$8,361,000
+59.8%
190,930
+87.9%
0.02%
+61.5%
Q1 2019$5,231,000
+741.0%
101,630
+503.9%
0.01%
+550.0%
Q4 2018$622,00016,8300.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q3 2021
NameSharesValueWeighting ↓
RP Management, LLC 2,111,111$144,294,00054.16%
Knoll Capital Management, LLC 856,844$58,565,00038.16%
ORACLE INVESTMENT MANAGEMENT INC 2,123,271$145,126,00021.73%
KINGDON CAPITAL MANAGEMENT, L.L.C. 860,261$58,799,0006.01%
ARS Investment Partners, LLC 561,442$38,375,0004.46%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 176,400$12,057,0003.19%
Eventide Asset Management 2,015,000$137,725,0002.04%
Avidity Partners Management LP 1,049,800$71,754,0001.98%
SILVERARC CAPITAL MANAGEMENT, LLC 50,089$3,424,0001.87%
Nicholas Investment Partners, LP 375,654$25,676,0001.79%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders